Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Mental Health and Quality of Life
Article in Journal of the Canadian Association of Gastroenterology (November 2021)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
Evaluation of economic burden with biologic treatments in Crohn’s disease patients: A mirror image study using an insurance database in Japan
Article in PLOS ONE (July 2021)
Effect of Originator Infliximab Treatment on Disease-Related Hospitalizations, Work Productivity and Activity Impairment, and Health Resource Utilization in Patients with Crohn’s Disease in a Real-Life Setting: Results of a Prospective Multicenter Study in Germany
Article in Inflammatory Intestinal Diseases (December 2020)